Neuropathix, Inc. Stock price
Equities
NPTX
US64132Q1094
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 18-07-24 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-07-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 17-06-19 |
Timothy Scott
BRD | Director/Board Member | 71 | 18-07-24 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.45% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |